Literature DB >> 19925831

Expression of a PTS2-truncated hexokinase produces glucose toxicity in Leishmania donovani.

Ramesh Kumar1, Suman Gupta, Rashmi Srivastava, Amogh A Sahasrabuddhe, Chhitar M Gupta.   

Abstract

Compartmentalization of glycolytic enzymes in glycosomes is vital in trypanosomatid parasites. Retention of these enzymes in the cytosol induces sugar toxicity and accumulation of intermediate metabolites, notably the hexokinase product glucose-6-phosphate. However, the role of hexokinase in sugar mediated toxicity remains unexplored. We have generated Leishmania donovani transfectants expressing a catalytically active cytosolic mutant of hexokinase. In the presence of glucose, these transfectants exhibited toxicity during log and stationary phases of growth. These results suggest that targeting of hexokinase to the glycosome is required to prevent uncontrolled and cytotoxic glucose phosphorylation in L. donovani parasites.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925831     DOI: 10.1016/j.molbiopara.2009.11.002

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  4 in total

1.  Mannogen-ing Central Carbon Metabolism by Leishmania.

Authors:  Kai Zhang; Stephen M Beverley
Journal:  Trends Parasitol       Date:  2019-10-26

2.  Glycolysis in the african trypanosome: targeting enzymes and their subcellular compartments for therapeutic development.

Authors:  April F Coley; Heidi C Dodson; Meredith T Morris; James C Morris
Journal:  Mol Biol Int       Date:  2011-04-11

3.  Glycosome turnover in Leishmania major is mediated by autophagy.

Authors:  Benjamin Cull; Joseane Lima Prado Godinho; Juliany Cola Fernandes Rodrigues; Benjamin Frank; Uta Schurigt; Roderick Am Williams; Graham H Coombs; Jeremy C Mottram
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

4.  Evidence for loss of a partial flagellar glycolytic pathway during trypanosomatid evolution.

Authors:  Robert W B Brown; Peter W Collingridge; Keith Gull; Daniel J Rigden; Michael L Ginger
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.